Intriguingly, in epithelial ovarian cancer, the increases in EVI1 DNA copy number and MDS1/EVI1 transcripts were associated with improved patient outcomes, whereas EVI1 transcript levels were associated with a poor patient survival. Here, MECOM is linked to ovarian carcinoma.